| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2027 ( Subtotal = $0 ) |
| | 2027 | 2026 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | UH3CA247606 | Multi-parametric Perfusion MRI for Therapy Response Assessment in Brain Cancer | 000 | 5 | NIH | 11/17/2026 | $0 |
|
 | Issue Date FY: 2026 ( Subtotal = $29,163,010 ) |
| | 2026 | 2026 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R01ES021488 | Imaging Biomarkers of Neurotoxicity in Welders | 000 | 11 | NIH | 7/14/2026 | $42,835 |
| | 2026 | 2026 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R33NS127268 | Diffusion MRI Biomarkers of Peripheral Nerve Trauma | 000 | 3 | NIH | 8/20/2026 | $821,164 |
| | 2026 | 2026 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R01AG081286 | Default mode network dysfunction in Down Syndrome | 000 | 2 | NIH | 4/3/2026 | $735,569 |
| | 2026 | 2026 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | F31NS139617 | Microglia- Astrocyte Crosstalk in Cortical Neurodegeneration of C9orf72 ALS/FTD | 000 | 2 | NIH | 8/3/2026 | $46,300 |
| | 2026 | 2026 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R01NS138528 | Endothelial complement C3a receptor mediated cerebral injury in a murine stroke model. | 000 | 2 | NIH | 8/20/2026 | $701,372 |
| | 2026 | 2026 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R01ES035388 | South African Manganese EnvironmentaL NeuroToxic Effects Research (SMELTER) | 001 | 3 | NIH | 7/6/2026 | $156,845 |
| | 2026 | 2026 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R01ES035388 | South African Manganese EnvironmentaL NeuroToxic Effects Research (SMELTER) | 000 | 3 | NIH | 6/23/2026 | $417,289 |
| | 2026 | 2026 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | UH3CA247606 | Multi-parametric Perfusion MRI for Therapy Response Assessment in Brain Cancer | 001 | 5 | NIH | 7/7/2026 | $496,204 |
| | 2026 | 2026 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R01AG089239 | An Integrative Computational Multimodal approach to disentangle Pathophysiologic Heterogeneity of age-related White Matter Hyperintensities | 000 | 3 | NIH | 5/5/2026 | $775,830 |
| | 2026 | 2026 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R01NS124575 | Multi-scale functional connectivity in preclinical models of Parkinson's disease | 001 | 5 | NIH | 3/24/2026 | $39,938 |
| | 2026 | 2026 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R01NS124575 | Multi-scale functional connectivity in preclinical models of Parkinson's disease | 000 | 5 | NIH | 12/12/2025 | $359,442 |
| | 2026 | 2026 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R01AG077780 | Roles of aging and cellular senescence in the development of intracranial aneurysm rupture | 000 | 4 | NIH | 2/23/2026 | $608,992 |
| | 2026 | 2026 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R01HL156891 | Chronic Lung Allograft Dysfunction: Role for Tumor Suppressor LKB1 in Exosomes | 000 | 5 | NIH | 6/12/2026 | $421,731 |
| | 2026 | 2026 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R01AG073212 | Repurposing Siponimod for Alzheimer's Disease | 000 | 4 | NIH | 8/28/2026 | $684,437 |
| | 2026 | 2026 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | OT2NS136939 | Access for All in ALS (ALL ALS) West Clinical Coordinating Center | 001 | 1 | NIH | 9/8/2026 | $25,322,772 |
| | 2026 | 2025 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R01NS115815 | A Translational Evaluation of Sur1-Trpm4 Imaging Endophenotypes and Genetics to Direct Precision Medicine for Cerebral Edema After Traumatic Brain Injury | 000 | 5 | NIH | 1/30/2026 | $0 |
| | 2026 | 2025 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R01NS120331 | Microglia contribution to disease pathogenesis in C9orf72 ALS/FTD | 000 | 5 | NIH | 7/2/2026 | $0 |
| | 2026 | 2025 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R01NS120331 | Microglia contribution to disease pathogenesis in C9orf72 ALS/FTD | 000 | 5 | NIH | 7/2/2026 | $0 |
| | 2026 | 2025 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | UH3CA247606 | Multi-parametric Perfusion MRI for Therapy Response Assessment in Brain Cancer | 000 | 4 | NIH | 3/6/2026 | $0 |
| | 2026 | 2024 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R61NS127268 | Diffusion MRI Biomarkers of Peripheral Nerve Trauma | 000 | 2 | NIH | 9/28/2026 | $0 |
| | 2026 | 2024 | DIGNITY HEALTH | 350 W Thomas Rd | Phoenix | AZ | 85013-4409 | MARICOPA | USA | GE153343 | Community Project Funding/Congressionally Directed Spending - Non-Construction | 03 | 1 | HRSA | 2/20/2026 | $0 |
| | 2026 | 2024 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | P01AG014449 | Neurobiology of Mild Cognitive Impairment in the Elderly | 000 | 26 | NIH | 1/27/2026 | $0 |
| | 2026 | 2024 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R21NS131689 | A Single Cell and Proteomic Precision Medicine Approach to Glyburide Responsive Contusion Expansion in Severe Traumatic Brain Injury | 000 | 2 | NIH | 8/13/2026 | $0 |
| | 2026 | 2024 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R01NS109584 | Mechanisms for intracranial aneurysm rupture | 000 | 5 | NIH | 5/19/2026 | $0 |
| | 2026 | 2023 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | RF1AG081286 | Default mode network dysfunction in Down Syndrome | 000 | 1 | NIH | 8/11/2026 | $0 |
| | 2026 | 2023 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R01NS109382 | EGF-ADAM17 axis in the pathophysiology of intracranial aneurysm | 000 | 5 | NIH | 4/29/2026 | -$18,586 |
| | 2026 | 2023 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R01ES029524 | NOVEL PET MARKERS OF COGNITIVE IMPAIRMENT IN MANGANESENEUROTOXICITY | 000 | 5 | NIH | 12/3/2025 | -$412,625 |
| | 2026 | 2023 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | OT2NS136939 | Access for All in ALS (ALL ALS) West Clinical Coordinating Center | 000 | 1 | NIH | 9/8/2026 | $0 |
| | 2026 | 2023 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R01AG059008 | MCLENA-1: A Clinical Trial for the Assessment of Lenalidomide in Amnestic MCI Patients | 002 | 5 | NIH | 2/5/2026 | -$2,005,331 |
| | 2026 | 2023 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R01AG059008 | MCLENA-1: A Clinical Trial for the Assessment of Lenalidomide in Amnestic MCI Patients | 001 | 5 | NIH | 10/1/2025 | -$31,168 |
| | 2026 | 2023 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R21NS125535 | Investigating the role of cerebral perfusion in demyelination and repair in multiple sclerosis with MRI | 000 | 2 | NIH | 2/11/2026 | $0 |
| | 2026 | 2022 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R21NS128550 | Transcriptomic assessment of pathology in PD with dementia and dementia with Lewy Bodies using iPSC neurons and brain tissue of the same individuals | 000 | 1 | NIH | 4/10/2026 | $0 |
| | 2026 | 2022 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R21NS130492 | Mechanisms of A-I RNA editing-mediated nuclear export of TDP-43 | 000 | 1 | NIH | 4/22/2026 | $0 |
|
 | Issue Date FY: 2025 ( Subtotal = $23,765,774 ) (Continued on the next page) |
| | 2025 | 2025 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R01NS120331 | Microglia contribution to disease pathogenesis in C9orf72 ALS/FTD | 003 | 5 | NIH | 9/8/2025 | $64,322 |
| | 2025 | 2025 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | UH3CA247606 | Multi-parametric Perfusion MRI for Therapy Response Assessment in Brain Cancer | 002 | 4 | NIH | 6/25/2025 | $328,637 |
| | 2025 | 2025 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R01ES035388 | South African Manganese EnvironmentaL NeuroToxic Effects Research (SMELTER) | 000 | 2 | NIH | 8/7/2025 | $401,669 |
| | 2025 | 2025 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | F31NS139617 | Microglia- Astrocyte Crosstalk in Cortical Neurodegeneration of C9orf72 ALS/FTD | 001 | 1 | NIH | 8/13/2025 | $0 |
| | 2025 | 2025 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | F31NS139617 | Microglia- Astrocyte Crosstalk in Cortical Neurodegeneration of C9orf72 ALS/FTD | 000 | 1 | NIH | 8/13/2025 | $45,724 |
| | 2025 | 2025 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R01ES035388 | South African Manganese EnvironmentaL NeuroToxic Effects Research (SMELTER) | 001 | 2 | NIH | 8/16/2025 | $183,548 |
| | 2025 | 2025 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R01AG089239 | An Integrative Computational Multimodal approach to disentangle Pathophysiologic Heterogeneity of age-related White Matter Hyperintensities | 003 | 2 | NIH | 6/20/2025 | $63,942 |
| | 2025 | 2025 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R01AG089239 | An Integrative Computational Multimodal approach to disentangle Pathophysiologic Heterogeneity of age-related White Matter Hyperintensities | 002 | 2 | NIH | 4/24/2025 | $719,342 |
| | 2025 | 2025 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R01NS124575 | Multi-scale functional connectivity in preclinical models of Parkinson's disease | 001 | 4 | NIH | 7/23/2025 | $39,938 |
| | 2025 | 2025 | DIGNITY HEALTH | 350 W THOMAS RD | PHOENIX | AZ | 85013-4409 | MARICOPA | USA | R01NS124575 | Multi-scale functional connectivity in preclinical models of Parkinson's disease | 000 | 4 | NIH | 11/21/2024 | $359,442 |
| | 2025 | 2025 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R01AG077780 | Roles of aging and cellular senescence in the development of intracranial aneurysm rupture | 001 | 3 | NIH | 6/18/2025 | $48,720 |
| | 2025 | 2025 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R01AG077780 | Roles of aging and cellular senescence in the development of intracranial aneurysm rupture | 000 | 3 | NIH | 3/25/2025 | $548,093 |
| | 2025 | 2025 | DIGNITY HEALTH | 185 BERRY ST STE 200 | SAN FRANCISCO | CA | 94107-1777 | SAN FRANCISCO | USA | R01HL156891 | Chronic Lung Allograft Dysfunction: Role for Tumor Suppressor LKB1 in Exosomes | 000 | 4 | NIH | 7/16/2025 | $417,885 |
|